Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
11/2008
11/05/2008CN101297918A Chinese medicine for treating tuberculosis
11/05/2008CN101297902A Dietary cure cool paste formulation for transforming hepatitis B í«great three positiveí» into negative and improving immunity
11/05/2008CN101297896A Method for extracting antipyretic and detoxicated oral liquid using cellulase
11/05/2008CN101297893A Chinese medicinal compound formulation for treating hepatitis
11/05/2008CN101297890A Chinese medicine powder for treating salpingitis of layer chicken and preparation thereof
11/05/2008CN101297889A Chinese medicine preparation for treating foot-and-mouth disease and preparation method thereof
11/05/2008CN101297883A Chinese medicinal composition for treating Canine parvovirus infection and preparation thereof
11/05/2008CN101297882A Chinese medicine preparation for treating infectious serositis of duck and preparation method thereof
11/05/2008CN101297879A Interferon Chinese medicament inducer composition for treating avian virus disease and preparation
11/05/2008CN101297865A Method from extracting total flavones from guava leaves
11/05/2008CN101297859A Chinese medicine preparation for treating duck virus hepatitis and preparation method thereof
11/05/2008CN101297858A Oral liquid for treating infection by avian viruses mixed with salmonella and preparation
11/05/2008CN101297826A Compound Bupleurum injection for curing common cold of dog and preparation thereof
11/05/2008CN101297821A Phellinus linteus mycelia active glucoprotein and use thereof and preparation
11/05/2008CN101297814A Emulsifiable paste for curing acne and preparation thereof
11/05/2008CN101297813A Compound niacin norfloxacin injection for animals and preparation thereof
11/05/2008CN101297812A Use of Tulathromycin compound for curing respiratory disease of fowl
11/05/2008CN101297809A Preparation of cefoperazone and sulbactam sodium mixed powder
11/05/2008CN101297808A Compound ofloxacin injection for fowl and preparation method thereof
11/05/2008CN101297802A Preparation and use of silybin bis-bias succinate oxymatrine double salt and matrine double salt
11/05/2008CN101297794A Compound kanamycin sulphate injection for dogs and preparation thereof
11/05/2008CN101297793A Injection for curing diarrhea of pig and preparation thereof
11/05/2008CN101297692A Extraction of glycosides from Vaccinium dunalianum Wight var. dunalianum and use thereof in health products
11/05/2008CN101297678A Chinese medicine antibacterial medicinal composition for curing livestock and poultry intestinal canal diseases and preparation thereof
11/05/2008CN101297655A Compound formulation for killing bacillus spore
11/05/2008CN100430482C Novel expression vectors and uses thereof
11/05/2008CN100430414C Tripeptides having a hydroxyproline ether of a substituted quinoline for the inhibition of NS3 (hepatitis C)
11/05/2008CN100430390C Water-soluble triazole fungicide
11/05/2008CN100430067C Carboxylate-gated-nitroxide (CGN) compounds and compositions and methods of use thereof
11/05/2008CN100430061C The use of endoperoxides for the treatment of infections caused by flaviviridae, including hepatitis c, bovine viral diarrhea and classical swine fever virus
11/05/2008CN100430053C AIDS therapeutic drug and its uses
11/05/2008CN100430049C Depressant of functions developed by molecule
11/04/2008US7446183 Fusion protein comprising growth hormone and growth hormone receptor
11/04/2008US7446182 Recombinant antibodies for the detection and neutralization of anthrax toxin
11/04/2008US7446175 Antibodies to human IL-1β
11/04/2008US7446173 amino acid sequence coupled to a non-naturally-occurring polyoxyalkylene glycol at N-terminal end of glycosylated interferon-beta-1a through a coupling group such as aldehyde, maleimide, a vinylsulfone,or haloacetate groups; enhanced activity; Multiple sclerosis; cancer; therapeutical; water solubility
11/04/2008US7446102 Antibacterial amide macrocycles IV
11/04/2008US7446091 Methods and preparations for curing clinically ill patients
11/04/2008US7445928 Bacterial artificial chromosome construct encoding recombinant coronavirus
11/04/2008US7445781 Inhibits B-cell activation by binding to protein receptor on helper T-cell membrane; treatment of allergy or autoimmune disease
11/04/2008US7445768 Delivery of sedative-hypnotics through an inhalation route
11/04/2008US7445764 Carrier-drug conjugate
11/04/2008CA2525550C Acridone-derived compounds useful as antiretroviral agents
11/04/2008CA2443449C Pyrazole derivatives for treating hiv
11/04/2008CA2362481C Echinocandin pharmaceutical formulations containing micelle-forming surfactants
11/04/2008CA2301943C Antimicrobial compounds
11/04/2008CA2182890C Targeted cytolysis of hiv-infected cells by chimeric cd4 receptor-bearing cells
11/04/2008CA2136870C Anti-aids immunomodulation complex
11/02/2008CA2587064A1 Antimicrobial gel for skin
10/2008
10/30/2008WO2008131134A1 Hydrazide compounds and uses thereof
10/30/2008WO2008130879A2 Tetrahydroindole and tetrahydroindazole derivatives
10/30/2008WO2008130261A1 Treatment of infections by carbon monoxide
10/30/2008WO2008129288A2 Disulfonamides useful in the treatment of inflammation
10/30/2008WO2008128962A1 Tricyclic compounds as antibacterials
10/30/2008WO2008128961A1 Compounds
10/30/2008WO2008128953A1 Tricyclic nitrogen containing heterocycles as antibacterial agents
10/30/2008WO2008128942A1 Tricyclic nitrogen containing compounds as antibacterial agents
10/30/2008WO2008128832A1 Nitroderivatives of non-peptidic renin inhibitors for the treatment of cardiovascular, renal and chronic liver disease, inflammations and metabolic syndrome
10/30/2008WO2008128654A2 Use of fungicides for treating fish mycoses
10/30/2008WO2008128640A1 Use of fungicides for treating fish mycoses
10/30/2008WO2008128627A2 Topically applicable fungicide agents for treating nails
10/30/2008WO2008128344A1 Small-molecule hepatitis c virus (hcv) ns3/4a serine protease inhibitors
10/30/2008WO2008128340A1 Antibacterial compositions comprising an extract from arceuthobium
10/30/2008WO2008128295A1 Essential oil of kunzea ambigua and methods of use
10/30/2008WO2008106980A3 Recombinant antibodies for treatment of respiratory syncytial virus infections
10/30/2008WO2008073311A3 Substituted diazepine sulfonamides as bombesin receptor subtype-3 modulators
10/30/2008WO2008056264A3 Novel nucleotide analogues as percursor molecules for antivirals
10/30/2008WO2008051416A3 Compounds that inhibit the activity of hsp90 for treating infections
10/30/2008WO2008046860A3 Bioavailable combinations for hcv treatment
10/30/2008WO2008022204A3 Thiourea compounds
10/30/2008WO2008021049A9 Crystalline antifungal compounds
10/30/2008WO2008021049A2 Crystalline antifungal compounds
10/30/2008US20080269875 Coating for a Medical Device Having an Anti-Thrombotic Conjugate
10/30/2008US20080269488 Characterized by x-ray reflections at 8.4 degrees, 10.8 degrees, 20.0 degrees, 20.4 degrees, and 21.2 degrees +-0.2 degrees 2 theta.
10/30/2008US20080269338 Aqueous solutions containing chloramine which are free from di-and trichloroamine, as well as from ammonia
10/30/2008US20080269333 Anthranilic acid derivatives useful in treating infection with hepatitis c virus
10/30/2008US20080269289 Vanilloid receptor ligand compounds, pharmaceutical compositions containing them, a method of producing them and the use thereof to treat pain and various other conditions
10/30/2008US20080269274 Using imiquimod; rubbing into surface
10/30/2008US20080269260 Using a purine compound; antiallergens; antiinflammatory agents; cognition activators; drug abuse; schizophenia; Alzheimer's disease; Parkinson's disease
10/30/2008US20080269240 Immunomoderator; antiallergens; viricides; anticancer agents; asthma; rhinitis; hepatitis; skin disorders
10/30/2008US20080269232 Pyridazine compound; also useful against rhinovirus
10/30/2008US20080269228 Hydrazide-containing hepatitis c serine protease inhibitors
10/30/2008US20080269227 Autoimmune diseases; antiinflamamtory agents, cardiovascular disorders; neurodegenerative diseases, kidney diseases, anticancer agents; platelet aggregation
10/30/2008US20080269214 Therapy for bacteria infections
10/30/2008US20080269207 Anticancer agents; such as 4-acetylamino-1H-pyrazole-3-carboxylic acid (4-fluoro-phenyl)-amide
10/30/2008US20080269205 Methods to prevent vertical transmission of infectious diseases
10/30/2008US20080269192 Chiral Fused [1,2]Imidazo[4,5-C] Ring Compounds
10/30/2008US20080269176 New Salts
10/30/2008US20080269175 Silicone permeated with therapeutic agents; butyl acetate solvent; minocycline, rifampin, clonidine, sulindac; drug-loaded polymeric boots, sheaths, discs; elute drug more rapidly
10/30/2008US20080269172 (1-{5-[(4-amino-benzenesulfonyl)-isobutyl-amino]-6-phosphonooxy-hexacarbomoyl}-2,2-diphenyl-ethyl)-carbamic acid methyl ester; which upon cleavage of cleavable bond or unit generates HIV-1 aspartyl protease inhibitor; antiviral agent; good solubility, and bioavailability; HIV or HTLV infection
10/30/2008US20080269162 Sulphated or phosphated polysaccharide in combination with AZT, Viramune, Agnerase, enfuvirtide; anti-nausea agents, anti-diarrhea agents, anti-hyperbilirubinemia, analgesic, dermatological treatment agents, anti-nephrotoxic agents; lentiviruses, oncoviruses, HIV
10/30/2008US20080269157 Prostate cancer-specific alterations in ERG gene expression and detection and treatment methods based on those alterations
10/30/2008US20080269152 Nucleic acid binding oligonucleotides
10/30/2008US20080269151 Antigen, nucleic acid that encodes fusion protein; diagnosis, prevention, therapy of tuberculosis
10/30/2008US20080269148 Using vector comprising nucleotide sequences which interfere with viral gene expression for prevention and treatment of hepatitis c viral infection; gene expression inhibition
10/30/2008US20080269147 Used in targeting specific mRNAs for degradation in mammalian cells where use of long dsRNAs to elicit RNAi is usually not practical, presumably because of the deleterious effects of the interferon response; autoimmune disease; tumor-associated gene
10/30/2008US20080269146 4''-Substituted Erythromycin Derivative
10/30/2008US20080269145 broad spectrum antibiotic activity; Gram-positive bacteria such as Clostridium, Staphylococcus, Enterococcus species; comprises tiacumicin B, lipiarmycin A4, and at least one of other macrocyclic compounds
10/30/2008US20080269128 Albumin Fusion Proteins
10/30/2008US20080269127 Albumin Fusion Proteins
1 ... 680 681 682 683 684 685 686 687 688 689 690 691 692 693 694 695 696 697 698 699 700 ... 1798